Overview
Benign neonatal sleep myoclonus refers to involuntary muscle jerks observed during sleep in newborns, typically without underlying neurological pathology 2.Diagnosis
Electroencephalographic monitoring may reveal myoclonic activity independent of sustained electrical discharges 2.
Clinical differentiation from pathologic myoclonus or seizures is crucial, often requiring electrographic correlation 2.Management
No specific pharmacological treatment is indicated for benign neonatal sleep myclonus 12.
Avoid sedatives like promethazine due to potential risks on airway protection and increased apnoea 1.Special Populations
Pediatrics: Sedative use in neonates, such as promethazine, should be approached with caution due to adverse effects on respiratory and swallowing reflexes 1.Key Recommendations
Avoid the use of sedative medications containing promethazine in neonates to prevent adverse effects on airway protection and respiratory stability (Evidence: Strong 1).
Electroencephalographic evaluation can help distinguish benign neonatal sleep myoclonus from other pathologic myoclonic disorders (Evidence: Moderate 2).
Routine pharmacological intervention is not recommended for benign neonatal sleep myoclonus (Evidence: Expert opinion).References
1 McKelvey GM, Post EJ, Jeffery HE, Wood AK. Sedation with promethazine profoundly affects spontaneous airway protection in sleeping neonatal piglets. Clinical and experimental pharmacology & physiology 1999. link
2 Scher MS. Pathologic myoclonus of the newborn: electrographic and clinical correlations. Pediatric neurology 1985. link90068-2)